Verano Holdings (VRNO) Cost of Revenue (2021 - 2026)

Verano Holdings' (VRNO) quarterly Cost of Revenue came in at $109.2 million in Q1 2026, down 0.93% year-on-year from $110.2 million in Q1 2025, and up 8.21% on a QoQ basis from $100.9 million in Q4 2025.

Verano Holdings (VRNO) Cost of Revenue (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Cost of Revenue data on file, last reported at $109.2 million in Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 0.93% year-over-year to $109.2 million in Q1 2026; TTM through Mar 2026 was $407.0 million, a 6.77% decrease from a year earlier, with the FY2025 full-year figure at $408.0 million, down 6.13% from the prior year.
  • Cost of Revenue for Q1 2026 stood at $109.2 million, up from $100.9 million in the prior quarter.
  • Over the last five years, Cost of Revenue for VRNO reached as high as $125.5 million in Q2 2022 and fell as low as $1.1 million in Q1 2022.
  • Historically, Cost of Revenue has averaged $104.1 million across 5 years, with a median of $108.3 million in 2024.
  • Across the five-year window, Cost of Revenue surged 11104.85% in 2023 and slipped 17.36% in 2025, its largest moves.
  • Year by year, Cost of Revenue stood at $122.6 million in 2022, then retreated by 2.46% to $119.6 million in 2023, then decreased by 7.45% to $110.7 million in 2024, then decreased by 8.81% to $100.9 million in 2025, then grew by 8.21% to $109.2 million in 2026.
  • Per Business Quant data, the three most recent Cost of Revenue figures were $109.2 million in Q1 2026, $100.9 million in Q4 2025, and $107.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 2.01 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 641.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 2.59 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 133.40 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 2.36 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 13.80 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 586.00 Mn
10 Verano Holdings 1.99 Bn 1.91 Bn 98.98 Mn 109.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 109.20 Mn
Mar 31, 2026 109.20 Mn
Dec 31, 2025 100.92 Mn
Dec 31, 2025 100.92 Mn
Sep 30, 2025 107.57 Mn
Sep 30, 2025 107.57 Mn
Jun 30, 2025 89.29 Mn
Jun 30, 2025 89.29 Mn
Mar 31, 2025 110.23 Mn
Mar 31, 2025 110.23 Mn
Dec 31, 2024 110.67 Mn
Dec 31, 2024 110.67 Mn
Sep 30, 2024 107.59 Mn
Sep 30, 2024 107.59 Mn
Jun 30, 2024 108.05 Mn
Jun 30, 2024 108.05 Mn
Mar 31, 2024 108.35 Mn
Mar 31, 2024 108.35 Mn
Dec 31, 2023 119.58 Mn
Dec 31, 2023 119.58 Mn